Home / CAD / Laurent Pharmaceuticals Receives a CAD 2.7M Financing from BioMed Propulsion Fund

Laurent Pharmaceuticals Receives a CAD 2.7M Financing from BioMed Propulsion Fund

MONTREAL–(BUSINESS WIRE)–Laurent Pharmaceuticals Inc. (the “Company”), a biopharmaceutical company focusing on rare diseases, today announced that it has received the final approval for a CAD 2.7M …
Read Full Story at source (may require registration)